VOGLIOS GM1

VOGLIOS GM1 is a triple-combination anti-diabetic formulation containing Voglibose 0.2 mg, Glimepiride 1 mg, and Metformin 500 mg (Sustained Release). It is designed for the effective management of Type 2 Diabetes Mellitus, offering controlled and prolonged blood sugar regulation throughout the day.

Key Benefits 

•  Controls fasting and post-prandial blood sugar levels
•  Provides sustained glucose control with SR technology
•  Enhances insulin secretion and sensitivity
•  Reduces risk of sudden glucose fluctuations
• Suitable for long-term Type 2 diabetes management